Arcturus Therapeutics is actively engaged in partnering discussions. Our strategic alliances fall into several categories:
- Partnering RNA medicines, including access to LUNAR and UNA Technologies
- Co-Development Opportunities
Please contact bd@arcturusrx.com regarding any business development opportunities.
News & Events
June 13, 2019
Arcturus Therapeutics Announces Redomiciliation to the United States as a Delaware Corporation
May 20, 2019
Arcturus Therapeutics Presenting Data for ARCT-810 and the Arcturus mRNA + LUNAR® Technology Platform at the 2019 Annual Meeting of TIDES: Oligonucleotide and Peptide Therapeutics
May 13, 2019
Arcturus Therapeutics Announces First Quarter Financial Results and Provides a Corporate Update